Compare PTGX & BMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTGX | BMA |
|---|---|---|
| Founded | 2006 | 1966 |
| Country | United States | Argentina |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.4B |
| IPO Year | 2016 | 2006 |
| Metric | PTGX | BMA |
|---|---|---|
| Price | $105.55 | $82.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 5 |
| Target Price | ★ $108.23 | $96.75 |
| AVG Volume (30 Days) | ★ 713.3K | 282.0K |
| Earning Date | 05-05-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 4.47% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $873.97 | $16.25 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $33.22 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $41.29 | $38.30 |
| 52 Week High | $107.84 | $106.15 |
| Indicator | PTGX | BMA |
|---|---|---|
| Relative Strength Index (RSI) | 59.61 | 61.22 |
| Support Level | $76.63 | $64.88 |
| Resistance Level | $107.84 | $94.54 |
| Average True Range (ATR) | 4.03 | 3.44 |
| MACD | -0.12 | 0.98 |
| Stochastic Oscillator | 84.57 | 90.45 |
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. It generates the majority of its revenue from Argentina.